News

Clinical Trials Arena6d
MSD’s Enflonsia receives FDA approval for RSV prophylaxis
MSD's Enflonsia (clesrovimab) has received US Food and Drug Administration (FDA) approval for the prevention of respiratory ...
Fierce Pharma9d
Merck scores FDA nod for Enflonsia, setting up RSV market battle vs. Sanofi and AstraZeneca's Beyfortus
Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...
MPR7d
Enflonsia Approved for RSV Disease Prevention in Infants
The Food and Drug Administration (FDA) has approved Enflonsia ™ (clesrovimab-cfor) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants who ...
Pharmaceutical Technology on MSN8d
MSD receives FDA approval for Enflonsia to prevent RSV
The approval was based on data from the pivotal Phase IIb/III CLEVER trial which assessed a single dose of the antibody.